219 related articles for article (PubMed ID: 2258623)
1. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
2. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
[TBL] [Abstract][Full Text] [Related]
3. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
5. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
[TBL] [Abstract][Full Text] [Related]
7. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.
Suzuki T; Hirai H; Fujisawa J; Fujita T; Yoshida M
Oncogene; 1993 Sep; 8(9):2391-7. PubMed ID: 8361755
[TBL] [Abstract][Full Text] [Related]
8. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
10. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs.
Bednarik DP; Duckett C; Kim SU; Perez VL; Griffis K; Guenthner PC; Folks TM
New Biol; 1991 Oct; 3(10):969-76. PubMed ID: 1768651
[TBL] [Abstract][Full Text] [Related]
11. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
12. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
13. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
[TBL] [Abstract][Full Text] [Related]
14. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
Bachelerie F; Alcami J; Arenzana-Seisdedos F; Virelizier JL
Nature; 1991 Apr; 350(6320):709-12. PubMed ID: 2023633
[TBL] [Abstract][Full Text] [Related]
15. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
16. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes.
Bressler P; Pantaleo G; Demaria A; Fauci AS
J Immunol; 1991 Oct; 147(7):2290-4. PubMed ID: 1680914
[TBL] [Abstract][Full Text] [Related]
18. Induction of NF-KB during monocyte differentiation by HIV type 1 infection.
Suzan M; Salaun D; Neuveut C; Spire B; Hirsch I; Le Bouteiller P; Querat G; Sire J
J Immunol; 1991 Jan; 146(1):377-83. PubMed ID: 1984449
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review).
Al-Harthi L; Roebuck KA
Int J Mol Med; 1998 May; 1(5):875-81. PubMed ID: 9852310
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
